Simultaneous Adalimumab and Antitubercular Treatment for Latent Tubercular Infection: An Experience from Nepal

Table 4

Characteristics of patients developing tubercular pleural effusion (n=2).

	Patient 1	Patient 2
Age in years	23	29
Disease duration in months	96	22
HLA B27	Positive	Positive
TST at baseline	Negative	Negative
IGRA at baseline	Negative	Negative
ASDAS CRP at baseline	2.97	4.15
CXR	Right sided pleural effusion	Right sided pleural effusion
HRCT chest	Rt sided pleural effusion with; mediastinal lymph node
CRP mg/L	120	29.0
AFB	Not seen	Not seen
Pleural fluid
TC per cumm	2960	4389
DC %	N 17, L 80	N 9, L 91
Protein gm%	5.7	4.9
Glucose mg%	79	56
ADA U/L	31.4	62.3
LDH	523	324
Culture	No growth	No growth
Adalimumab dose	dose (6 months gap)	(4 months gap)